Levine Cancer Insitute Carolinas Healthcare System — Charlotte, North Carolina

Levine Cancer Insitute Carolinas Healthcare System is a clinical research site located in Charlotte, North Carolina, United States 28204.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Levine Cancer Insitute Carolinas Healthcare System has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Paroxysmal Nocturnal Hemoglobinuria (PNH), Sickle Cell Disease (SCD), Acute Myeloid Leukemia.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlotte

Browse all research sites in North Carolina · View every site in Charlotte

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Levine Cancer Insitute Carolinas Healthcare System?

Levine Cancer Insitute Carolinas Healthcare System has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Levine Cancer Insitute Carolinas Healthcare System conducted?

Levine Cancer Insitute Carolinas Healthcare System has 3 clinical trials on record, with 1 currently active. Their work covers Paroxysmal Nocturnal Hemoglobinuria (PNH), Sickle Cell Disease (SCD), Acute Myeloid Leukemia.

Is Levine Cancer Insitute Carolinas Healthcare System accredited by Crixeo Clinical Trials?

Levine Cancer Insitute Carolinas Healthcare System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Levine Cancer Insitute Carolinas Healthcare System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.